AVITA Medical, Inc. Revenue from Contract with Customer, Including Assessed Tax
AVITA Medical, Inc. (RCEL) reported Revenue from Contract with Customer, Including Assessed Tax of $21.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $21.49M, a 17.90% increase year-over-year.
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $19.06M, a 4.03% increase year-over-year.
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $17.43M, a 4.29% decline year-over-year.
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $16.90M, a 12.88% decline year-over-year.
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $70.88M, a 10.93% increase from fiscal 2024.
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $63.89M, a 27.42% increase from fiscal 2023.
- AVITA Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $50.14M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.49M 10-Q · filed 2026-08-06 | $40.55M 10-Q · filed 2026-08-06 | $57.98M derived: sum of 3 quarters · filed 2026-08-06 | $74.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $19.06M 10-Q · filed 2026-05-14 | $36.49M derived: sum of 2 quarters · filed 2026-05-14 | $53.39M derived: sum of 3 quarters · filed 2026-05-14 | $71.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $34.33M derived: sum of 2 quarters · filed 2026-02-12 | $52.55M derived: sum of 3 quarters · filed 2026-08-06 | $70.88M 10-K · filed 2026-02-12 |
| 2025-09-30 | $16.90M 10-Q · filed 2025-11-06 | $35.12M derived: sum of 2 quarters · filed 2026-08-06 | $53.45M 10-Q · filed 2025-11-06 | $71.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $18.23M 10-Q · filed 2026-08-06 | $36.55M 10-Q · filed 2026-08-06 | $54.76M derived: sum of 3 quarters · filed 2026-08-06 | $74.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.32M 10-Q · filed 2026-05-14 | $36.54M derived: sum of 2 quarters · filed 2026-05-14 | $55.93M derived: sum of 3 quarters · filed 2026-05-14 | $71.11M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $18.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $37.61M derived: sum of 2 quarters · filed 2026-02-12 | $52.79M derived: sum of 3 quarters · filed 2026-02-12 | $63.89M 10-K · filed 2026-02-12 |
| 2024-09-30 | $19.39M 10-Q · filed 2025-11-06 | $34.58M derived: sum of 2 quarters · filed 2025-11-06 | $45.68M 10-Q · filed 2025-11-06 | $59.88M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $15.18M 10-Q · filed 2025-08-08 | $26.29M 10-Q · filed 2025-08-08 | $40.48M derived: sum of 3 quarters · filed 2025-08-08 | $54.13M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $11.10M 10-Q · filed 2025-05-08 | $25.30M derived: sum of 2 quarters · filed 2025-05-08 | $38.94M derived: sum of 3 quarters · filed 2025-05-08 | $50.70M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $27.84M derived: sum of 2 quarters · filed 2025-02-13 | $39.59M derived: sum of 3 quarters · filed 2025-02-13 | $50.14M 10-K · filed 2025-02-13 |
| 2023-09-30 | $13.64M 10-Q · filed 2024-11-07 | $25.40M derived: sum of 2 quarters · filed 2024-11-07 | $35.95M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $11.75M 10-Q · filed 2024-08-08 | $22.30M 10-Q · filed 2024-08-08 |